EUCTR2008-000248-15-FR进行中（未招募）不适用
Amikacine nébulisée à forte dose. Pharmacocinétique dans la pneumonie associée à la ventilation mécaniqueD’ARTAGNAN 3 - Dartagnan3
Association pour la promotion de la réanimation médicale à Tours0 个研究点目标入组 24 人开始时间: 2008年6月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients hospitalized in the intensive care unit and undergoing mechanical ventilation for more than 48h and presenting a clinical, radiological and biological sucpicion of ventilator associated pneumonia.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Allergy to amikacin or any component of the IMPs
- •Acute or chronic kidney failure.
- •Myasthenia gravis.
- •Vestibulo-cochlear disorders.
研究者
相似试验
招募中
Unknown
Effect of inhaled Amikacin and Colistin in prevention of pneumoniaIRCT20201015049030N3Tehran University of Medical Sciences126
进行中（未招募）
1 期
ebulized Amikacine for Ventilator associated gram negative Pneumonia in ECMO veno-arterial patients: A randomized Pilot Study (NAVAP-ECMO)gram-negative bacillus pneumonia acquired during mechanical ventilation in patients receiving Extracorporeal Membrane veno-arterial oxygenationMedDRA version: 20.1Level: LLTClassification code: 10035701Term: Pneumonia gram-negative bacterial NOS Class: 10021881MedDRA version: 20.0Level: SOCClassification code: 10021881Term: Infections and infestations Class: 1CTIS2023-509722-22-00Assistance Publique Hopitaux De Paris26
尚未招募
不适用
A study on relationship of dosage of Amikacin drug with levels in blood.CTRI/2021/08/035823Manipal Center for infectious Diseases
已完成
不适用
The safety and feasibility of inhaled amikacin for treatment of refractory chronic lower respiratory tract infectionschronic lower respiratory tract infectionsJPRN-UMIN000017874Center for Infectious Diseases and Infection Control, Keio University School of Medicine30
进行中（未招募）
1 期
AKAPI: Amikacin Liposome Inhalation Suspension for treatment of Mycobacterium xenopi pulmonary infection: A prospective controlled open-label randomized studyCTIS2023-506843-40-00Centre Hospitalier Universitaire Amiens Picardie190